Page last updated: 2024-08-23

paroxetine and Neurally Mediated Faint

paroxetine has been researched along with Neurally Mediated Faint in 6 studies

Research

Studies (6)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	4 (66.67)	18.2507
2000's	2 (33.33)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Banks, K; Hamdan, MH; Joglar, JA; Kowal, RC; Li, JM; Page, RL; Smith, ML; Takata, TS; Wasmund, SL	1
Elliott, PM; Frenneaux, MP; McKenna, WJ; Mist, B; Murphy, RT; Shah, JS; Thaman, R; Williams, L	1
Barbone, C; Barsotti, A; Di Girolamo, E; Di Iorio, C; Leonzio, L; Sabatini, P	1
Calkins, H	1
Barsotti, A; Di Girolamo, E; Di Iorio, C; Leonzio, L; Ranalli, G; Sabatini, P	1

Reviews

1 review(s) available for paroxetine and Neurally Mediated Faint

Article	Year
Pharmacologic approaches to therapy for vasovagal syncope. The American journal of cardiology, 1999, Oct-21, Volume: 84, Issue:8A Topics: Atenolol; Fludrocortisone; Humans; Midodrine; Paroxetine; Randomized Controlled Trials as Topic; Syncope, Vasovagal; Treatment Outcome	1999

Trials

4 trial(s) available for paroxetine and Neurally Mediated Faint

Article	Year
Serotonin reuptake inhibitor (Paxil) does not prevent the vasovagal reaction associated with carotid sinus massage and/or lower body negative pressure in healthy volunteers. Circulation, 2002, Sep-17, Volume: 106, Issue:12 Topics: Animals; Baroreflex; Blood Pressure; Carotid Sinus; Cats; Double-Blind Method; Female; Heart Rate; Humans; Lower Body Negative Pressure; Male; Massage; Paroxetine; Rats; Selective Serotonin Reuptake Inhibitors; Sympathetic Nervous System; Syncope, Vasovagal	2002
Reversal of inappropriate peripheral vascular responses in hypertrophic cardiomyopathy. Journal of the American College of Cardiology, 2005, Sep-06, Volume: 46, Issue:5 Topics: Adrenergic beta-Antagonists; Adult; Blood Pressure; Cardiomyopathy, Hypertrophic, Familial; Clonidine; Cross-Over Studies; Double-Blind Method; Exercise Test; Female; Humans; Lower Extremity; Male; Paroxetine; Propranolol; Syncope, Vasovagal; Vasodilation	2005
Effects of paroxetine hydrochloride, a selective serotonin reuptake inhibitor, on refractory vasovagal syncope: a randomized, double-blind, placebo-controlled study. Journal of the American College of Cardiology, 1999, Volume: 33, Issue:5 Topics: Acute Disease; Adult; Double-Blind Method; Electrocardiography, Ambulatory; Female; Follow-Up Studies; Humans; Male; Middle Aged; Paroxetine; Refractory Period, Electrophysiological; Secondary Prevention; Selective Serotonin Reuptake Inhibitors; Syncope, Vasovagal; Tilt-Table Test; Treatment Outcome	1999
[Effectiveness of paroxetine in the treatment of refractory vasovagal syncope in young patients]. Giornale italiano di cardiologia, 1999, Volume: 29, Issue:12 Topics: Adult; Age Factors; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Paroxetine; Selective Serotonin Reuptake Inhibitors; Syncope, Vasovagal	1999

Other Studies

1 other study(ies) available for paroxetine and Neurally Mediated Faint

Article	Year
Antidepressants for fainting spells. Harvard heart letter : from Harvard Medical School, 1999, Volume: 10, Issue:1 Topics: Humans; Paroxetine; Recurrence; Selective Serotonin Reuptake Inhibitors; Syncope; Syncope, Vasovagal; Tilt-Table Test	1999